Home / Products / Cancer (Tumor) Cell Lines / EFM-192C
EFM-192C
Datasheet Protocol

EFM-192C

Cat. No. ARC0190
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Breast

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

EFM-192C is a cancer cell line of breast carcinoma, isolated from metastatic; pleural effusion.

Recommended Products

HDAC3 Knockout THP-1 Polyclonal Cells HDAC3 Knockout THP-1 Polyclonal Cells Cat. No. ARG23481 ARHGEF10 Knockout A549 Polyclonal Cells ARHGEF10 Knockout A549 Polyclonal Cells Cat. No. ARG31598 ALDH1A1 Knockout 786-O Polyclonal Cells ALDH1A1 Knockout 786-O Polyclonal Cells Cat. No. ARG35166 DNAJC19 Knockout MES-OV Polyclonal Cells DNAJC19 Knockout MES-OV Polyclonal Cells Cat. No. ARG39236 DIP2A Knockout HCT116 Polyclonal Cells DIP2A Knockout HCT116 Polyclonal Cells Cat. No. ARG38772 MBLAC2 Knockout MES-OV Polyclonal Cells MBLAC2 Knockout MES-OV Polyclonal Cells Cat. No. ARG5939
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Breast
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
46 years
Sex of Donor:
Female
Derived From Site:
Metastatic; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

LUC7L Knockout NCI-H1975 Polyclonal Cells

LUC7L Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG17370
 HACD4 Knockout HAP1 Polyclonal Cells

HACD4 Knockout HAP1 Polyclonal Cells

Cat. No. ARG22447
 ARHGAP1 Knockout SK-HEP-1 Polyclonal Cells

ARHGAP1 Knockout SK-HEP-1 Polyclonal Cells

Cat. No. ARG32235
 ARL6IP1 Knockout HT29 Polyclonal Cells

ARL6IP1 Knockout HT29 Polyclonal Cells

Cat. No. ARG33041
 ACO1 Knockout HT29 Polyclonal Cells

ACO1 Knockout HT29 Polyclonal Cells

Cat. No. ARG32832
 CCS Knockout HAP1 Polyclonal Cells

CCS Knockout HAP1 Polyclonal Cells

Cat. No. ARG43350